CSPG4 and acute lymphoblastic leukemia: In vitro, anti-NG2 treatment was unable to activate effector mechanisms including CDC (Fig. 2a, b) and ADCC (Fig. 2c), resulting in no cytotoxicity of NG2-expressing MLLr-B-ALL cells in 4- and 24-h assays.